Page 22 of 28

PA21.1-6 | Blood Grouping, Crossmatch & Autologous Transfusion — Part 1

CLINICAL SCENARIO

A 28-year-old woman arrives in the OT for an elective myomectomy. The blood bank technician labels two tubes from the same patient — but one label was written hastily and the tube numbers are transposed. The crossmatch is set up with the wrong sample. The patient's ABO group is O; the donor unit is A. The immediate-spin crossmatch shows 3+ agglutination — incompatible — and the unit is held back. A clerical catch saved a life.

This is why blood grouping and crossmatching exists: every single step is a deliberate safety gate.

WHY THIS MATTERS

PA21.6 makes blood grouping and crossmatching examinable as a practical skill — you must be able to perform the technique, not merely describe it. PA21.5 pairs this with autologous transfusion, a patient-safety strategy that avoids allogeneic blood altogether. Together, these competencies form the core of pre-transfusion testing in any blood bank or operation-theatre setting. You will encounter these scenarios in your clinical rotations, casualty, and surgical postings — and they are high-yield for university practicals and MBBS exit assessments.

RECALL

Before you begin, activate what you already know:

  • ABO system: Four blood groups — A, B, AB, O — determined by surface antigens on red cells. Which antibodies does each group carry in serum? (Hint: Landsteiner's rule — if you lack the antigen, you have the antibody.)
  • Rh system: The D antigen is the most clinically significant. What happens when an Rh-negative mother carries an Rh-positive foetus?
  • Agglutination: When antibody meets its antigen on red cells, they clump — agglutination. This visible reaction is the readout for almost every blood-group test.

If any of these feel shaky, revisit the Blood Groups & ABO/Rh SDL (H12-SDL1) before continuing.

Why Two Tests? The Logic of Forward and Reverse Grouping

⚑ AI image — pending faculty review (auto-QA score 5/10; best of 3 attempts)

Diagram showing how ABO blood grouping uses forward testing of patient red cells against antisera and reverse testing of patient serum against reagent red cells, with matching results interpreted by Landsteiner's rule.

Forward and Reverse ABO Grouping

Panel A: Patient blood sample, patient red cells, patient serum/plasma, two simultaneous tests, forward grouping, reverse grouping. Panel B: Forward grouping: patient RBCs, Anti-A serum, Anti-B serum, Anti-D serum, agglutination indicates antigen present, A antigen, B antigen, D antigen. Panel C: Reverse grouping: patient serum/plasma, reagent A cells, reagent B cells, agglutination indicates antibody present, anti-A antibody, anti-B antibody. Panel D: Landsteiner's rule consistency table: group A, group B, group AB, group O, Anti-A result, Anti-B result, A-cell result, B-cell result, matching forward and reverse patterns.

ABO grouping uses two complementary reactions run simultaneously.

Forward (cell) grouping — also called direct or cell typing — tests the patient's red cells against known commercial antisera:
• Patient RBCs + Anti-A serum
• Patient RBCs + Anti-B serum
• Patient RBCs + Anti-D serum (for Rh typing)

Agglutination with Anti-A means the A antigen is present → group A (or AB).

Reverse (serum) grouping — also called back-typing or serum typing — tests the patient's serum/plasma against known red cells:
• Patient serum + Reagent A cells (group A red cells)
• Patient serum + Reagent B cells

The results must be internally consistent (Landsteiner's rule):

Forward groupingReverse groupingABO group
Anti-A +, Anti-B −A cells −, B cells +A
Anti-A −, Anti-B +A cells +, B cells −B
Anti-A +, Anti-B +A cells −, B cells −AB
Anti-A −, Anti-B −A cells +, B cells +O

If forward and reverse disagree, this is a grouping discrepancy — work must halt and the discrepancy investigated (see later block).

Blood grouping test plate showing agglutination patterns for Group A Rh-positive sample with forward and reverse typing results clearly marked with positive and negative symbols.

Forward and Reverse Blood Grouping Results for Group A Rh-Positive Sample

Panel A: Blood grouping test plate with five wells showing Anti-A (+), Anti-B (-), Anti-D (+), A-cells (-), B-cells (+) reactions. Panel B: Microscopic comparison of agglutinated versus non-agglutinated red blood cells. Panel C: Results interpretation table confirming Group A Rh-positive blood type.

Why run both? Each is a cross-check on the other. A label mix-up (wrong patient sample) will produce a discrepancy — you catch the error before transfusing.

Methods: Slide, Tube, and Gel-Card

Comparison diagram showing slide, tube, and gel-card blood grouping methods with their workflow, interpretation, limitations, and agglutination grading.

Blood Grouping Methods and Agglutination Grading

Panel A: Slide method showing glass slide, whole blood drop, anti-A / anti-B antiserum drop, mixing area, 2-4 minute read time, drying artifact warning, and screening-only limitation.. Panel B: Tube method showing blood sample, antiserum, incubation temperatures, centrifugation, button resuspension, positive agglutination, negative smooth suspension, forward grouping, and reverse grouping.. Panel C: Gel-card method showing micro-columns, dextran-acrylamide gel, reagent antisera, sample wells, centrifugation, trapped agglutinates, bottom cell pellet, and advantages of column agglutination.. Panel D: Agglutination grading scale showing 0, 1+, 2+, 3+, and 4+ reactions for both tube and gel-card methods..

Three bench methods are in use. Know their hierarchy:

1. Slide method
• Drops of whole blood and antiserum placed on a glass slide; rocked for 2 minutes.
• Advantages: rapid (screening, emergencies).
• Limitations: drying artifact can mimic agglutination; only 2–4 minutes read time; cannot detect weak reactions; unsuitable for reverse grouping.
• Not recommended as a standalone confirmatory test.

2. Tube method (traditional gold standard)
• Blood sample + antiserum in a test tube; incubate at appropriate temperature; centrifuge; read button resuspension.
• Reliable for both forward and reverse grouping.
• Allows multiple incubation temperatures (room temperature, 37°C, 4°C) — essential for detecting cold-reactive antibodies.
• Reading button resuspension: gently tilt tube; agglutinates = positive (solid clump or granular); smooth suspension = negative.

3. Gel-card (column agglutination) method
• Micro-columns filled with dextran-acrylamide gel containing pre-dispensed reagent antisera.
• Cells and serum added to the well; card centrifuged.
• Agglutinates are trapped in the gel column; free (unagglutinated) cells pellet to the bottom.
• Advantages: standardised, reproducible, permanent visual record, graded reactions (0 to 4+), no wash step needed.
• Used in modern blood banks for routine and antibody-screening work.

Agglutination grading (tube and gel card):

GradeAppearance
4+One solid clump, clear background
3+Several large clumps, clear background
2+Medium clumps, slightly turbid background
1+Small clumps, turbid background
w+Tiny clumps visible only microscopically
0Smooth, no clumps
Five gel-card columns showing graduated agglutination reactions from strong positive (4+) with red band at top to negative (0) with pellet at bottom.

Gel-Card Column Agglutination Grading System

Panel A: Five gel-card columns showing 4+ (solid red band at top), 2+ (moderate agglutination), 1+ (weak agglutination), weak positive (minimal reaction), and 0 (negative with pellet at bottom).

SELF-CHECK

A technician performs forward grouping: Anti-A shows 3+ agglutination, Anti-B shows no agglutination. Reverse grouping shows no reaction with reagent A cells and 3+ with reagent B cells. What is the ABO blood group?

A. Blood group B

B. Blood group A

C. Blood group AB

D. Blood group O

Reveal Answer

Answer: B. Blood group A

Forward grouping: Anti-A positive → A antigen present; Anti-B negative → no B antigen. Reverse grouping: A cells negative → no anti-A in serum; B cells positive → anti-B in serum. This is a concordant result consistent with group A (Landsteiner's rule: group A individuals have anti-B). Option A would require Anti-B positive forward + A cells positive reverse.

Rh Typing and the Weak-D Problem

A four-panel diagram explains routine Rh(D) typing, weak-D detection by Du/IAT testing, donor and recipient labelling rules, and the alloimmunisation risk of misclassifying a weak-D donor.

Rh Typing and the Weak-D Problem

Panel A: Forward Rh(D) typing with patient or donor RBCs, IgM Anti-D saline reagent, agglutination indicating Rh-positive, and no agglutination indicating provisionally Rh-negative.. Panel B: Weak-D RBC with low-density D antigen expression, negative routine Anti-D screen, and positive indirect antiglobulin Du test.. Panel C: Weak-D donor labelled Rh-positive and weak-D recipient managed as Rh-positive, with notes on prevention of anti-D sensitisation.. Panel D: Misclassified weak-D donor unit transfused to an Rh-negative recipient, leading to anti-D alloantibody formation and the warning to perform Du/IAT on donor samples..

Rh typing is performed as part of forward grouping:
• Patient RBCs + Anti-D serum (IgM, saline-reactive)
• Agglutination = Rh-positive (D antigen present)
• No agglutination = provisionally Rh-negative

Weak D (Du): Some individuals express the D antigen at very low density — the initial Anti-D test is negative but indirect antiglobulin testing (IAT) is positive. Key points:
• Donors who are weak-D positive are labelled as Rh-positive (their blood can stimulate anti-D in recipients).
• Recipients who are weak-D positive are generally managed as Rh-positive (they rarely form anti-D).
• The distinction matters clinically — misclassifying a weak-D positive donor as Rh-negative could lead to alloimmunisation in an Rh-negative patient.

If the initial Anti-D screen is negative, a Du test (indirect antiglobulin test with Anti-D) should be performed on all donor samples.

SELF-CHECK

A blood donor's RBCs test negative with routine Anti-D saline reagent but positive on the indirect antiglobulin (Du) test. How should this donor be labelled?

A. Rh-negative — the primary test is the definitive one

B. Rh-indeterminate — requires repeat testing at a reference laboratory before labelling

C. Rh-positive — weak-D donors are labelled positive to prevent sensitisation in recipients

D. Rh-negative, but the unit must be irradiated before transfusion to any recipient

Reveal Answer

Answer: C. Rh-positive — weak-D donors are labelled positive to prevent sensitisation in recipients

Weak-D (Du) donors are classified as Rh-positive for labelling purposes. Although their D antigen density is low, their red cells can still stimulate anti-D antibody production in an Rh-negative recipient, causing alloimmunisation. Labelling them as Rh-positive prevents an Rh-negative patient from inadvertently receiving a D-antigen-positive unit. Irradiation (option D) prevents graft-versus-host disease from viable lymphocytes and is not the relevant concern here.